An Observational Study of Avastin and Conventional Chemotherapy in Patients >/= 70 Years of Age With Previously Untreated Metastatic Colorectal Cancer (AVAPLUS)

Roche

Status: Completed

Conditions: Colorectal Cancer

Study type: Observational

Funder types: Industry

Identifiers

NCT01676922

ML27768

Details and patient eligibility

About

This observational study will evaluate the use of Avastin (bevacizumab) and conventional chemotherapy in patients >/= 70 years of age with previously untreated metastatic colorectal cancer. Data will be collected from each patient from initiation of treatment until disease progression occurs (minimum follow-up 12 months).

Enrollment: 256 patients

Sex: All

Ages: 70+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adult patients, >/ 70 years of age
• Previously untreated metastatic colorectal cancer
• Patient considered suitable to receive chemotherapy with or without Avastin

Exclusion criteria

• Participation in any other clinical trial or study with the exception of participation in registries

Trial design

256 participants in 1 patient group

Cohort